This aligns with recent work by Parambil et al. (2024), who highlighted the role of NRG1-ERBB4 in activating pro-tumorigenic pathways, including the YAP signaling pathway, which promotes tumor cell proliferation and survival. Here, NRG1 is linked to neoplasm.